Attenuation of post-infarction remodeling in rats by sustained myocardial growth hormone administration

References

• Agathopoulos S, Kolettis TM. 2014. Editorial: Novel strategies for cardiac repair post-myocardial infarction. Curr Pharm Des 20:1925–1929
   PubMed Web of Science ®Google Scholar
• Aikawa Y, Rohde L, Plehn J, Greaves SC, Menapace F, Arnold MO, Rouleau JL, et al. 2001. Regional wall stress predicts ventricular remodeling after anteroseptal myocardial infarction in the Healing and Early Afterload Reducing Trial (HEART): An echocardiography-based structural analysis. Am Heart J 141:234–242
   PubMed Web of Science ®Google Scholar
• Anderson JM, Rodriguez A, Chang DT. 2008. Foreign body reaction to biomaterials. Semin Immunol 20:86–100
   PubMed Web of Science ®Google Scholar
• Augst AD, Kong HJ, Mooney DJ. 2006. Alginate hydrogels as biomaterials. Macromol Biosci 6:623–633
   PubMed Web of Science ®Google Scholar
• Baltogiannis GG, Tsalikakis DG, Mitsi AC, Hatzistergos KE, Elaiopoulos D, Fotiadis DI, Kyriakides ZS, Kolettis TM. 2005. Endothelin receptor-A blockade decreases ventricular arrhythmias after myocardial infarction in rats. Cardiovasc Res 67:647–654
   PubMed Web of Science ®Google Scholar
• Banquet S, Gomez E, Nicol L, Edwards-Levy F, Henry JP, Cao R, Schapman D, et al. 2011. Arteriogenic therapy by intramyocardial sustained delivery of a novel growth factor combination prevents chronic heart failure. Circulation 124:1059–1069
   PubMed Web of Science ®Google Scholar
• Bruel A, Oxlund H. 1999. The effect of growth hormone on rat myocardial collagen. Growth Horm IGF Res 9:123–130
   PubMed Web of Science ®Google Scholar
• Chintalgattu V, Nair DM, Katwa LC. 2003. Cardiac myofibroblasts: A novel source of vascular endothelial growth factor (VEGF) and its receptors Flt-1 and KDR. J Mol Cell Cardiol 35:277–286
   PubMed Web of Science ®Google Scholar
• Cittadini A, Grossman JD, Napoli R, Katz SE, Stromer H, Smith RJ, Clark R, et al. 1997. Growth hormone attenuates early left ventricular remodeling and improves cardiac function in rats with large myocardial infarction. J Am Coll Cardiol 29:1109–1116
   PubMed Web of Science ®Google Scholar
• Cittadini A, Isgaard J, Monti MG, Casaburi C, Di Gianni A, Serpico R, Iaccarino G, Sacca L. 2003. Growth hormone prolongs survival in experimental postinfarction heart failure. J Am Coll Cardiol 41:2154–2163
   PubMed Web of Science ®Google Scholar
• Cittadini A, Strömer H, Katz SE, Clark R, Moses AC, Morgan JP, Douglas PS. 1996. Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat. A combined in vivo and in vitro evaluation. Circulation 93:800–809
   PubMed Web of Science ®Google Scholar
• Cochain C, Channon KM, Silvestre JS. 2013. Angiogenesis in the infarcted myocardium. Antioxid Redox Signal 18:1100–1113
   PubMed Web of Science ®Google Scholar
• Cook JJ, Haynes KM, Werther GA. 1988. Mitogenic effects of growth hormone in cultured human fibroblasts. Evidence for action via local insulin-like growth factor I production. J Clin Invest 81:206–212
   PubMed Web of Science ®Google Scholar
• Daskalopoulos EP, Hermans KC, Blankesteijn WM. 2014. Cardiac (myo)fibroblast: Novel strategies for its targeting following myocardial infarction. Curr Pharm Des 20:1987–2002
   PubMed Web of Science ®Google Scholar
• de Jong R, van Hout GP, Houtgraaf JH, Kazemi K, Wallrapp C, Lewis A, Pasterkamp G, et al. 2014. Intracoronary infusion of encapsulated glucagon-like peptide-1-eluting mesenchymal stem cells preserves left ventricular function in a porcine model of acute myocardial infarction. Circ Cardiovasc Interv 7:673–683
   PubMed Web of Science ®Google Scholar
• Elaiopoulos DA, Tsalikakis DG, Agelaki MG, Baltogiannis GG, Mitsi AC, Fotiadis DI, Kolettis TM. 2007. Growth hormone decreases phase II ventricular tachyarrhythmias during acute myocardial infarction in rats. Clin Sci (Lond) 112:385–391
   PubMed Web of Science ®Google Scholar
• Ertl G, Frantz S. 2005. Healing after myocardial infarction. Cardiovasc Res 66:22–32
   PubMed Web of Science ®Google Scholar
• Frangogiannis NG. 2014. The inflammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol 11:255–265
   PubMed Web of Science ®Google Scholar
• Friberg L, Werner S, Eggertsen G, Ahnve S. 2000. Growth hormone and insulin-like growth factor-1 in acute myocardial infarction. Eur Heart J 21:1547–1554
   PubMed Web of Science ®Google Scholar
• Hao X, Silva EA, Mansson-Broberg A, Grinnemo KH, Siddiqui AJ, Dellgren G, Wardell E, et al. 2007. Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction. Cardiovasc Res 75:178–185
   PubMed Web of Science ®Google Scholar
• Hatzistergos KE, Mitsi AC, Zachariou C, Skyrlas A, Kapatou E, Agelaki MG, Fotopoulos A, et al. 2008. Randomised comparison of growth hormone versus IGF-1 on early post-myocardial infarction ventricular remodelling in rats. Growth Horm IGF Res 18:157–165
   PubMed Web of Science ®Google Scholar
• Jayasankar V, Pirolli TJ, Bish LT, Berry MF, Burdick J, Grand T, Woo YJ. 2004. Targeted overexpression of growth hormone by adenoviral gene transfer preserves myocardial function and ventricular geometry in ischemic cardiomyopathy. J Mol Cell Cardiol 36:531–538
   PubMed Web of Science ®Google Scholar
• Jin H, Yang R, Lu H, Ogasawara AK, Li W, Ryan A, Peale F, Paoni NF. 2002. Effects of early treatment with growth hormone on infarct size, survival, and cardiac gene expression after acute myocardial infarction. Growth Horm IGF Res 12:208–215
   PubMed Web of Science ®Google Scholar
• Khan AS, Lynch CD, Sane DC, Willingham MC, Sonntag WE. 2001. Growth hormone increases regional coronary blood flow and capillary density in aged rats. J Gerontol A Biol Sci Med Sci 56:B364–B371
   PubMed Web of Science ®Google Scholar
• Kolettis TM. 2006. Arrhythmogenesis after cell transplantation post-myocardial infarction. Four burning questions-and some answers. Cardiovasc Res 69:299–301
   PubMed Web of Science ®Google Scholar
• Kolettis TM, Agelaki MG, Baltogiannis GG, Vlahos AP, Mourouzis I, Fotopoulos A, Pantos C. 2007. Comparative effects of acute vs. chronic oral amiodarone treatment during acute myocardial infarction in rats. Europace 9:1099–1104
   PubMed Web of Science ®Google Scholar
• Kolettis TM, Vilaeti A, Dimos K, Tsitou N, Agathopoulos S. 2011. Tissue engineering for post-myocardial infarction ventricular remodeling. Mini Rev Med Chem 11:263–270
   PubMed Web of Science ®Google Scholar
• Kontonika M, Barka E, Daskalopoulos EP, Vilaeti AD, Papalois A, Agathopoulos S, Kolettis TM. 2014. Effects of myocardial alginate injections on ventricular arrhythmias after experimental ischemia-reperfusion. Trends Biomater Artif Organs 28:79–82
   Google Scholar
• Laeremans H, Hackeng TM, van Zandvoort MA, Thijssen VL, Janssen BJ, Ottenheijm HC, Smits JF, Blankesteijn WM. 2011. Blocking of frizzled signaling with a homologous peptide fragment of wnt3a/wnt5a reduces infarct expansion and prevents the development of heart failure after myocardial infarction. Circulation 124:1626–1635
   PubMed Web of Science ®Google Scholar
• Landa N, Miller L, Feinberg MS, Holbova R, Shachar M, Freeman I, Cohen S, Leor J. 2008. Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation 117:1388–1396
   PubMed Web of Science ®Google Scholar
• Lee SW, Kim SH, Kim JY, Lee Y. 2010. The effect of growth hormone on fibroblast proliferation and keratinocyte migration. J Plast Reconstr Aesthet Surg 63:e364–e369
   PubMed Web of Science ®Google Scholar
• Mitsi AC, Hatzistergos K, Baltogiannis GG, Kolettis TM. 2005. Early, selective growth hormone administration may ameliorate left ventricular remodeling after myocardial infarction. Med Hypotheses 64:582–585
   PubMed Web of Science ®Google Scholar
• Mitsi AC, Hatzistergos KE, Niokou D, Pappa L, Baltogiannis GG, Tsalikakis DG, Papalois A, et al. 2006. Early, intracoronary growth hormone administration attenuates ventricular remodeling in a porcine model of myocardial infarction. Growth Horm IGF Res 16:93–100
   PubMed Web of Science ®Google Scholar
• Mukherjee R, Zavadzkas JA, Saunders SM, McLean JE, Jeffords LB, Beck C, Stroud RE, et al. 2008. Targeted myocardial microinjections of a biocomposite material reduces infarct expansion in pigs. Ann Thorac Surg 86:1268–1276
   PubMed Web of Science ®Google Scholar
• Nagasawa N, Mitomo H, Yoshii F, Kume T. 2000. Radiation-induced degradation of sodium alginate. Polym Degrad Stabil 69:279–285
   Web of Science ®Google Scholar
• O’Sullivan JF, Leblond AL, Kelly G, Kumar AH, Metharom P, Buneker CK, Alizadeh-Vikali N, et al. 2011. Potent long-term cardioprotective effects of single low-dose insulin-like growth factor-1 treatment postmyocardial infarction. Circ Cardiovasc Interv 4:327–335
   PubMed Web of Science ®Google Scholar
• Omerovic E, Bollano E, Mobini R, Kujacic V, Madhu B, Soussi B, Fu M, et al. 2000. Growth hormone improves bioenergetics and decreases catecholamines in postinfarct rat hearts. Endocrinology 141:4592–4599
   PubMed Web of Science ®Google Scholar
• Pantos C, Mourouzis I, Markakis K, Tsagoulis N, Panagiotou M, Cokkinos DV. 2008. Long-term thyroid hormone administration reshapes left ventricular chamber and improves cardiac function after myocardial infarction in rats. Basic Res Cardiol 103:308–318
   PubMed Web of Science ®Google Scholar
• Porter KE, Turner NA. 2009. Cardiac fibroblasts: At the heart of myocardial remodeling. Pharmacol Ther 123:255–278
   PubMed Web of Science ®Google Scholar
• Robitaille R, Dusseault J, Henley N, Desbiens K, Labrecque N, Halle JP. 2005. Inflammatory response to peritoneal implantation of alginate-poly-L-lysine microcapsules. Biomaterials 26:4119–4127
   PubMed Web of Science ®Google Scholar
• Rowley JA, Madlambayan G, Mooney DJ. 1999. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 20:45–53
   PubMed Web of Science ®Google Scholar
• Ruvinov E, Leor J, Cohen S. 2011. The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction. Biomaterials 32:565–578
   PubMed Web of Science ®Google Scholar
• Struman I, Bentzien F, Lee H, Mainfroid V, D’Angelo G, Goffin V, Weiner RI, Martial JA. 1999. Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: An efficient mechanism for the regulation of angiogenesis. Proc Natl Acad Sci USA 96:1246–1251
   PubMed Web of Science ®Google Scholar
• Sutton MG, Sharpe N. 2000. Left ventricular remodeling after myocardial infarction: Pathophysiology and therapy. Circulation 101:2981–2988
   PubMed Web of Science ®Google Scholar
• Tanaka N, Ryoke T, Hongo M, Mao L, Rockman HA, Clark RG, Ross J Jr. 1998. Effects of growth hormone and IGF-I on cardiac hypertrophy and gene expression in mice. Am J Physiol 275:H393–H399
   PubMed Web of Science ®Google Scholar
• van den Borne SW, van de Schans VA, Strzelecka AE, Vervoort-Peters HT, Lijnen PM, Cleutjens JP, Smits JF, et al. 2009. Mouse strain determines the outcome of wound healing after myocardial infarction. Cardiovasc Res 84:273–282
   PubMed Web of Science ®Google Scholar
• Vilaeti AD, Dimos K, Lampri ES, Mantzouratou P, Tsitou N, Mourouzis I, Oikonomidis DL, et al. 2013. Short-term ventricular restraint attenuates post-infarction remodeling in rats. Int J Cardiol 165:278–284
   PubMed Web of Science ®Google Scholar
• Wright EJ, Farrell KA, Malik N, Kassem M, Lewis AL, Wallrapp C, Holt CM. 2012. Encapsulated glucagon-like peptide-1-producing mesenchymal stem cells have a beneficial effect on failing pig hearts. Stem Cells Transl Med 1:759–769
   Web of Science ®Google Scholar
• Yang D, Jones KS. 2009. Effect of alginate on innate immune activation of macrophages. J Biomed Mater Res A 90:411–418
   PubMed Web of Science ®Google Scholar